govt.fyi
Back to SB 2007
Oklahoma Legislature· SB 2007Vetoed 05/01/2026

An act relating to pharmacy benefits managers, the official text

Shown verbatim: the complete text as captured from the official PDF posted by the Oklahoma Legislature, fetched 2026-07-23. Page and line markers are part of the official record; nothing is edited or removed. The official bill page.
1                              STATE OF OKLAHOMA

1

2                  2nd Session of the 60th Legislature (2026)

2

3 SENATE BILL 2007              By: Wingard
3

4

4

5

5

6                              AS INTRODUCED

6

7   An Act relating to pharmacy benefits managers;

7   amending 59 O.S. 2021, Section 360, as last amended

8   by Section 8, Chapter 300, O.S.L. 2025 (59 O.S. Supp.

8   2025, Section 360), which relates to pharmacy

9   benefits manager contractual duties to provider;

9   requiring pharmacy benefits manager to remit certain

10  fees in certain situations; updating statutory

10  language; and providing an effective date.

11

11

12

12

13 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
13

14  SECTION 1.      AMENDATORY  59 O.S. 2021, Section 360, as last

14

15 amended by Section 8, Chapter 300, O.S.L. 2025 (59 O.S. Supp. 2025,
15

16 Section 360), is amended to read as follows:
16

17  Section 360. A. The pharmacy benefits manager (PBM) shall,

17

18 with respect to contracts between a pharmacy benefits manager and a
18

19 provider, including a pharmacy service administrative organization:
19

20  l. Include in such contracts the specific sources utilized to

20

21 determine the maximum allowable cost (MAC) pricing of the pharmacy,
21

22 update MAC pricing at least every seven (7) calendar days, and
22

23 establish a process for providers to readily access the MAC list
23

24 specific to that provider;
24

    Req. No. 3073                                              Page 1
1   2. In order to place a drug on the MAC list, ensure that the

1

2 drug is listed as "A" or "B" rated in the most recent version of the
2

3 United States Food and Drug Administration (FDA) Approved Drug
3

4 Products with Therapeutic Equivalence Evaluations, also known as the
4

5 Orange Book, and the drug is generally available for purchase by
5

6 pharmacies in the state from national or regional wholesalers and is
6

7 not obsolete;
7

8   3. Ensure dispensing fees are not included in the calculation

8

9 of MAC price reimbursement to pharmacy providers;
9

10  4. Provide a reasonable administration appeals procedure to

10

11 allow a provider, a provider's representative and a pharmacy service
11

12 administrative organization to contest reimbursement amounts within
12

13 fourteen (14) calendar days of the final adjusted payment date. The
13

14 pharmacy benefits manager shall not prevent the pharmacy or the
14

15 pharmacy service administrative organization from filing
15

16 reimbursement appeals in an electronic batch format. The pharmacy
16

17 benefits manager must PBM shall respond to a provider, a provider's
17

18 representative and a pharmacy service administrative organization
18

19 who have contested a reimbursement amount through this procedure
19

20 within ten (10) calendar days. The pharmacy benefits manager must
20

21 PBM shall respond in an electronic batch format to reimbursement
21

22 appeals filed in an electronic batch format. The pharmacy benefits
22

23 manager PBM shall not require a pharmacy or pharmacy services
23

24 administrative organization to log into a system to upload
24

    Req. No. 3073                                              Page 2
1 individual claim appeals or to download individual appeal responses.
1

2 If a price update is warranted, the pharmacy benefits manager PBM
2

3 shall make the change in the reimbursement amount, permit the
3

4 dispensing pharmacy to reverse and rebill the claim in question, and
4

5 make the reimbursement amount change retroactive and effective for
5

6 all contracted providers;
6

7  5. If a below-cost reimbursement appeal is denied, the PBM

7

8 shall provide the reason for the denial, including the National Drug
8

9 Code (NDC) number from, and the name of, the specific national or
9

10 regional wholesalers doing business in this state where the drug is
10

11 currently in stock and available for purchase by the dispensing
11

12 pharmacy at a price below the PBM's reimbursement price. The PBM
12

13 shall include documented proof from the specific national or
13

14 regional wholesalers doing business in this state showing that the
14

15 drug is currently in stock and available for purchase by the
15

16 dispensing pharmacy at a price below the PBM's reimbursement price.
16

17 If the NDC number provided by the pharmacy benefits manager PBM is
17

18 not available below the acquisition cost obtained from the
18

19 pharmaceutical wholesaler from whom the dispensing pharmacy
19

20 purchases the majority of the prescription drugs that are dispensed,
20

21 the pharmacy benefits manager PBM shall immediately adjust the
21

22 reimbursement amount, permit the dispensing pharmacy to reverse and
22

23 rebill the claim in question, and make the reimbursement amount
23

24 adjustment retroactive and effective for all contracted providers;
24

   Req. No. 3073                                                Page 3
1   6. If a PBM increases reimbursement for a drug, medical

1

2 product, or device as a result of an appeal pursuant to this
2

3 subsection, including an adjustment required pursuant to paragraph 5
3

4 of this subsection, and reduces the reimbursement amount for the
4

5 same drug, medical product, or device, including the same NDC
5

6 number, within thirty (30) calendar days of the appeal
6

7 determination, the PBM shall remit an administrative fee not less
7

8 than One Hundred Dollars ($100.00) to the affected provider for each
8

9 occurrence. If such fees are not remitted after ninety (90)
9

10 calendar days, the administrative fee shall not be less than Five
10

11 Hundred Dollars ($500.00) for each occurrence. If such fees are not
11

12 remitted after one hundred eighty (180) calendar days, the
12

13 administrative fee shall not be less than One Thousand Dollars
13

14 ($1,000.00);
14

15  7. Any appeal that results in an increase in the reimbursement

15

16 from the PBM that continues to be below the pharmacy's acquisition
16

17 cost shall be considered a denial under this section. Any denial of
17

18 an appeal shall follow the requirements of paragraph paragraphs 5
18

19 and 6 of this subsection; and
19

20  7. 8. The PBM shall not require a pharmacy to collect

20

21 additional monies following a successful below-cost reimbursement
21

22 appeal from any person or entity other than the PBM who adjudicated
22

23 the drug claim, including the patient or plan sponsor.
23

24

24

    Req. No. 3073                                              Page 4
1   B. The reimbursement appeal requirements in this section shall

1

2 apply to all drugs, medical products, or devices reimbursed
2

3 according to any payment methodology, including, but not limited to:
3

4   1. Average acquisition cost, including the National Average

4

5 Drug Acquisition Cost;
5

6   2. Average manufacturer price;

6

7   3. Average wholesale price;

7

8   4. Brand effective rate or generic effective rate;

8

9   5. Discount indexing;

9

10  6. Federal upper limits;

10

11  7. Wholesale acquisition cost; and

11

12  8. Any other term that a pharmacy benefits manager PBM or an

12

13 insurer of a health benefit plan may use to establish reimbursement
13

14 rates to a pharmacist or pharmacy for pharmacist services.
14

15  C. The pharmacy benefits manager PBM shall not place a drug on

15

16 a MAC list, unless there are at least two therapeutically
16

17 equivalent, multiple-source drugs, generally available for purchase
17

18 by dispensing retail pharmacies from national or regional
18

19 wholesalers.
19

20  D. In the event that a drug is placed on the FDA Drug Shortages

20

21 Database, pharmacy benefits managers PBMs shall reimburse claims to
21

22 pharmacies at no less than the wholesale acquisition cost for the
22

23 specific NDC number being dispensed.
23

24

24

    Req. No. 3073                                              Page 5
1   E. The pharmacy benefits manager PBM shall not require

1

2 accreditation or licensing of providers, or any entity licensed or
2

3 regulated by the State Board of Pharmacy, other than by the State
3

4 Board of Pharmacy or federal government entity as a condition for
4

5 participation as a network provider.
5

6   F. A pharmacy or pharmacist may decline to provide the

6

7 pharmacist clinical or dispensing services to a patient or pharmacy
7

8 benefits manager if the pharmacy or pharmacist is to be paid less
8

9 than the pharmacy's cost for providing the pharmacist clinical or
9

10 dispensing services.
10

11  G. The pharmacy benefits manager PBM shall provide a dedicated

11

12 telephone number, email address and names of the personnel with
12

13 decision-making authority regarding MAC appeals and pricing.
13

14  SECTION 2. This act shall become effective November 1, 2026.

14

15

15

16  60-2-3073      CAD   1/15/2026 9:49:42 AM

16

17

17

18

18

19

19

20

20

21

21

22

22

23

23

24

24

    Req. No. 3073                                           Page 6
Every fact on this page links to its source, starting with the official bill record.